NEW YORK – Becton Dickinson reported Thursday that its fiscal first quarter 2021 earnings rose 26 percent year over year attributed in part to $867 million in COVID-19 diagnostic sales.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.